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Abstract 
The 5'-AMP-activated protein kinase (AMPK) regulates the fatty acid and sterol synthesizing pathways via phosphorylation of
acetyl-CoA carboxylase and HMG-CoA reductase, respectively. Highly purified kinase from porcine liver contains three apparent 
subunits of molecular mass 63 kDa, 40 kDa and 38 kDa. Peptide sequencing of the 63 kDa protein (AMPK63ca t) revealed that this 
polypeptide is the catalytic subunit of the kinase. Porcine peptide sequences were used to clone by RT-PCR partial ength cDNAs for the 
catalytic domains of the porcine AMPK63ca t, and its rat homolog, which were virtually identical in deduced amino acid sequence. 
Screening of a rat liver cDNA library with these partial length cDNAs and with degenerate oligonucleotides yielded several unique 
clones, some of which had a 142 bp deletion in the catalytic domain of the kinase. A consensus full-length sequence with a 1.7 kb open 
reading frame has been constructed from overlapping library and PCR-derived clones. A large mRNA for rat AMPK63ca t (8.5 kb) is 
expressed in nearly all rat tissues, with highest levels detectable in heart and skeletal muscle. Using PCR, the presence of two mRNA 
species with or without the 142 bp deletion in the catalytic domain was noted in all rat tissues examined. Comparison of the deduced 
protein sequence of AMPK63c~ t reveals highly conserved homologies in both the catalytic and non-catalytic domains to several members 
of the SNF1 kinase family, including kinases from Arabidopsis, barley, rye, and S. cerevesiae, as well as to other mammalian kinases 
and to a C. elegans kinase. The high evolutionary conservation of both kinase structure and function (metabolite sensing) coupled with 
their pattern of tissue/organism expression suggest hat the mammalian members of this kinase family likely play wider roles than the 
regulation of cellular lipid metabolism. 
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1. Introduction 
Covalent enzyme phosphorylation plays a major role in 
the regulation of both the fatty acid and sterol synthesizing 
pathways. The rate-limiting enzyme of each pathway, 
acetyl-CoA carboxylase and HMG-CoA reductase, respec- 
tively, can both be phosphorylated and inactivated by a 
unique protein kinase, whose activity is stimulated by 
5'-AMP. The 5'-AMP-activated protein kinase (AMPK) 
has been extensively characterized in both mammalian and 
non-mammalian cells and tissues [1-9]. Recently, we have 
isolated the kinase to apparent homogeneity from porcine 
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liver [7]. The 63 kDa catalytic subunit of the kinase 
co-purifies with two other subunits of 40 and 38 kDa. 
Partial amino acid sequencing of the 63 kDa subunit 
revealed a striking amino acid homology between AMPK 
and the SNF1 protein kinase of Saccharomyces cerevisiae 
[7]. These results indicated that there has been high evolu- 
tionary conservation of the catalytic domain sequences of 
the SNF1 protein kinase family, suggesting broader roles 
for AMPK and AMPK-related kinases in eukaryotic ellu- 
lar metabolism. 
In the present study, we report the cloning of a cDNA 
for a rat homolog of the porcine 63 kDa catalytic subunit 
of AMPK (AMPK63ca t) from a rat liver cDNA library and 
of a partial length cDNA done for the porcine enzyme by 
the polymerase chain reaction. These cDNAs have been 
compared to other members of the SNF1 protein kinase 
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family and have been used for a characterization of
AMPK63ca t mRNA distribution i  rat tissues. 
nase 2 (United States Biochemical) as recommended by 
the manufacturer. 
2. Materials and methods 
2.1. Enzyme and RNA isolation and protein sequencing 
Porcine liver AMPK was isolated to homogeneity, as 
previously detailed [7]. The 63 kDa subunit was prote- 
olyzed and the resultant peptides purified and sequenced, 
as in [7]. RNA was isolated from porcine and rat liver by 
the method of Cathala and co-workers [10]. 
2.2. PCR cDNA probe construction 
Several of the peptide sequences (as detailed in [7]) 
were used to construct a cDNA for the catalytic domain of 
AMPK by the polymerase chain reaction. We took advan- 
tage of the general catalytic domain structure for all pro- 
tein kinases to design oligonucleotides for the appropriate 
strand, anticipating the construction of a cDNA of about 
375-400 bp [11]. cDNA synthesis was to be primed with 
the most C-terminal of these sequences and PCR per- 
formed with primers/nested primers derived from oppo- 
site ends of the catalytic domain sequences available. 
Three peptide sequences were selected for oligo design: 
For sense primers: VKIGHYILGDT For antisense primers: 
DLKPENVLLDAHMNAKI For cDNA synthesis primer: 
EHEWFKQ 
Five oligonucleotides were constructed with degeneracy 
reduced by the selective inclusion of inosines. The se- 
quences were: Primer for reverse transcription (RT): 5'- 
TI'(AG) AAC CA(CT) TC(AG) TG(CT) TC-3'; Sense 
primer: 5'-GT(GATC) AA(AG) AT(ATC) GG(GATC) 
CA(CT) TA-3'; Sense-nested: 5'-TA(CT) ATI (CT)TI GGI 
GA(CT) AC-3'; Antisense: 5'-AT(CT) TI'I GC(AG) "ITC 
AT(AG) TG-3'; Antisense-nested: 5'-q-'r(CT) TCI GG(CT) 
TI~I A(AG)(AG) TC-3'. 
Template for PCR was cDNA synthesized from either 
rat liver total RNA (2 /xg) or pig liver total RNA (2 /zg) 
using the SuperScript Preamplification System for First 
Strand cDNA Synthesis (Gibco BRL) and the RT oligo as 
primer. Using the GeneAmp PCR Core Reagents Kit (Per- 
kin-Elmer/Cetus), cDNA was amplified using the sense 
and antisense primers (250 pmol each) in 100 /zl reaction 
volumes. Amplification was performed using 40 cycles of 
94°C (1 min), 37°C (1 min), and 72°C (2 min). After the 
first round of amplification, o bands were visible on an 
ethidium bromide-stained agarose gel. Five /xl of first 
round products were re-amplified using the nested primers 
under the same cycling conditions. The major band (394 
bp) on an ethidium bromide stained gel was cut out, glass 
wool purified and cloned using the pT7Blue T-Vector Kit 
(Novagen). Plasmid DNA was prepared from positive 
clones and sequenced using dideoxynucleotides and Seque- 
2.3. cDNA library screening 
A rat liver AZap II cDNA library (Stratagene) was 
screened using the 394 bp catalytic domain PCR product. 
Phage plating and double-lifting onto nitrocellulose filters 
(Schleicher and Schull) was done according to manufac- 
turer's instructions. Filters were hybridized with 
[32p]cDNA, labeled with [ot-32p]CTP (3000 mCi/mmol, 
New England Nuclear) by random priming (Random 
Primers DNA Labeling System/Gibco BRL), in 50% for- 
mamide, 10 X Denhardt's, 1 M NaCI, 50 mM Tris (pH 
7.5), and 100 mg/ml salmon sperm DNA at 42°C for 18 
h. They were then washed briefly at room temperature and 
then at 55°C (3 X 30 min) with 2 X SSPE/0.1% SDS. 
Autoradiography was for 4-24 h at room temperature. 
The library was also screened with two degenerate 
oligonucleotides corresponding to selected peptide se- 
quences. These sequences were: 
5'-TC(CT) TG(CT)T-F(AG)AACCA(CT)TC(AG)- 
TG(CT) TC-3' 
5'- GA(CT) GC(AGCT)CA(CT)ATGAA(CT)- 
GC(ACGT)AA(AG)AT-3' 
corresponding to portions of determined amino acid se- 
quences (see above sequences used for antisense primer 
and cDNA synthesis primer). For this screening, oligo- 
nucleotides were end-labeled with [T-32p]ATP (3000 
mCi/mmol, New England Nuclear)) using a 5' DNA 
Terminus Labeling Kit (Gibco/BRL). Hybridization was 
carried out at 37°C in 5 × SSPE, 5 × Denhardt's and 0.1% 
SDS supplemented with yeast RNA (100 /zg/ml) and 
0.05% Na4P207 • 10H20. After hybridization, filters were 
washed three times at room temperature (5 min each) and 
then one time at 48°C for 15 min with 6 X SSPE, 0.1% 
SDS and 0.05% NaaP207 • 10H20. Autoradiography was 
for 16-24 h at -80°C. 
Positives from each screening method were plaque- 
purified on subsequent rounds of screening and phagemid 
from positive clones was rescued with helper phage 
(Stratagene). Screening of "-, 106 plaques with the PCR- 
derived cDNA yielded three unique clones; five indepen- 
dent clones were isolated from the degenerate oligonucleo- 
tide screening of ~ 2.4 • 106 pfu. 
2.4. DNA sequencing of clones 
All unique cDNA clones were independently sequenced 
in both laboratories by the dideoxynucleotide chain termi- 
nation method using Sequenase 2 (United States Biochemi- 
cal). Internal sequencing was performed using sequence- 
derived primers. 
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2.5. Northern analysis 
Total RNA was isolated from the tissues of male 
Sprague-Dawley rats (body weight 150-200 g, Charles 
River) using a guanidinium isothiocyanate-lithium chloride 
method, as in [10]. RNAs were fractionated on 1% 
agarose/formaldehyde gels with capillary transfer to nitro- 
cellulose (MSI). DNA probes were labeled by random 
priming, as above. Hybridization was carried out in 5 × 
Denhardt's, 50% formamide, 0.2 M Tris-HC1 (pH 7.4), 
0.86 M NaCI and 0.1 mg/ml  salmon sperm DNA at 42°C 
for 20 h. Filters were washed briefly at room temperature 
and then at 55°C in 0.1 × SSPE/0.1% SDS for 1.5 h with 
three changes. Autoradiography was at -80°C for 18-48 
h. 
the SAMS peptide in the presence of a maximally activat- 
ing concentration of 5'-AMP (200 /~M), as described 
previously [9]. Protein concentration was determined by a 
Coomassie Blue binding assay (Bio-Rad). 
2.7. Sequence comparisons and oligonucleotide design 
DNA and deduced amino acid sequences were analyzed 
by MacVector* software with data base accession through 
Entrez, Blast and dFlash [12,13]. Oliognucleotide se- 
quences were designed using OLIGO* software. Se- 
quences were formatted using Gene Construction Kit* and 
with an Excel* macro [14]. 
2.8. Nucleotide sequence accession umber 
2.6. Tissue extraction and kinase assay 
Tissues from Sprague-Dawley rats (body weight 150- 
200 g, Charles River) were collected and homogenized in
ice-cold buffer containing Tris-HC1 (20 mM, pH 7.4; 4°C), 
NaC1 (50 mM), NaF (50 mM) Na4P207 (5 mM), sucrose 
(0.25 M), ZnC12 (10/xM), sodium vanadate (0.1 mM) and 
dithiothreitol (2 mM). The latter three reagents were added 
just before use. The homogenates were clarified by centrif- 
ugation (14000 × g; 2 min) and saturated (NH4)2SO 4 was 
added to give a final concentration of 35%. The precipi- 
tates were collected by centrifugation (14 000 × g, 30 min) 
and resuspended in homogenization buffer. The activity of 
the 5'-AMP-activated protein kinase was assayed against 
The GenBank accession numbers for the cDNAs re- 
ported here are U12149 (rat cDNA) and U12148 (pig 
cDNA). 
3. Resul ts  
3.1. PCR cloning of rat and pig catalytic domain cDNAs 
The extensive amino acid sequence available from the 
catalytic domain of the porcine AMPK63ca t protein, cou- 
pled with knowledge of the general catalytic domain struc- 
ture of the protein kinase family [11], facilitated the PCR 
cloning of catalytic domain cDNAs for AMPK63~a t. eDNA 
A 
1 I0 20 30 40 50 60 
Rat LYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 
i:lilllllIIIll i]lilIIlllilLlllllliilllllllilllllllllIll[lll 
Pig -YMLGDTLGVGTFGKEKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 
70 80 90 I00 ii0 120 
Rat I IKLYQVISTPTGFFMVMEYVSGGELFDYICKHGSVEEVEARRLFQQILSAVDYCHRHMVVHRDLKPE 
ILllllilllll lilllJl]llIIIlllilEll lJI:llilJllllllilllllIlllll]lllll 
Pig IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPEK 
B 142 bp 
deletion 
EcoRI 
Pt2R 
I I I 
2.1kb 1.1kb 
Fig. 1. cDNA clones for pig liver AMPKca tand its rat homolog. (A) Comparison f the deduced amino acid sequence ofPCR-derived cDNAs for pig and 
rat AMPKea t. [ indicates amino acid identity; : indicates a highly conserved substitution. (B) Diagrammatic representation of the largest of the 
library-derived ratclones. The 1.7 kb open reading frame, represented by the wide bar, contains shading indicating the positions of the N-terminal catalytic 
domain (black hatched) and of the non-catalytic C-terminal domains homologous to other members of the SNF1 kinase family (stipple hatched). The 
position of the 142 bp deletion i  the catalytic domain i  this clone, as determined byalignment tothe original PCR product, is indicated with the arrow 
(see text). 
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1 GTC COG TGG GGG TGT GGC 
70 TTT AGG CAA ATG TTT AAG 
139 CGG CGG CGG CAG CGC GGC 
208 AAG CAC GAC GGG CGT 
6) Lys His G1 
277 AAA GTG ~ AT~ 
29)~ Val Lys Ile Gly 
346 ATT CGC AGT TTA GAT 
52~ Ile Arg Ser Leu Asp 
415 CAT ATT ATC AAA CTC 
75kills Ile Ile Lys Leu 
484 GGA GGT GAA TTG TTC 
98~Gly Gly GIu Leu Phe 
553 CAG CAG ATT CTG TCT 
121)Gln Gln Ile Leu Ser 
622 AAC GTG TTG CTG GAC 
144kAsn Val Leu Leu Asp 
691 GGT GAA TTT CTA CGA 
167~Giy Glu Phe Leu Arq 
760 TAT GCG GGT CCT GAG 
190~ Ala Glv Pro G]u 
829 COG TTC GAC GAT GAG 
213kPro Phe Asp Asp Glu 
898 TAT CTC AAC CGT TCT 
236k Tyr Leu Asn Arg Ser 
967 ATC AAA GAC ATA CGA 
259) Ile Lys Asp Ile Arq 
1036 TCC TAT GAT GCT AAC 
282~ Ser Tyr Asp Ala Asn 
1105 TCA GAA GTG ATG AAC 
305k Ser Glu Val Met Asn 
1174 ATT GAC AAT CGG AGA 
328kIle Asp Asn Arg Arg 
1243 TTC ATG GAC GAT AGT 
351~ Phe Met Asp Asp Ser 
1312 ATA GCA GAC AGC CCC 
374~Iie Ala Asp Ser Pro 
1381 GTG AAA AAA GCC AAG 
397~Vai Lys Lys A1a Lys 
1450 TAC CGA GCT ATG AAG 
420~Tyr Arg Ala Met Lys 
1519 AAA AAC CCA GTG ACT 
443)Lys Asn Pro Val Thr 
1588 CTT CTA GAC TTT AAA 
466~I~-n T~_n Ash Phi- T,v~ 
1657 TOC TGT TCT GCT GCC 
489kSer Cys Set Ala Ala 
1726 CTG TCT GGC TCT CTC 
512~Leu Ser Gly Ser Leu 
1795 CAT ACC ATG GAT TTT 
535~ His Thr Met Asp Phe 
1864 GGT CTC TGT CTT TCT 
1933 TAC CAC AGG CTC TGC 
2002 AAA TCT GGC CTT CTG 
TAG GCA AGG CGT CTT GAG CTA TAT 
GGA TTT TAC AOC GGT TTA TGG ATG 
GGC CTT AGA GOC CGC GGC CCG GGG 
GTG AAG ATC GGA CAC TAC GTG CTG GGG 
Val ~s  I le G~ His ~ Val Leu GIy 
GAA T CAA T ACA CAT AAA GTG 
Glu His Gln Leu Thr Gly His Lys Val 
GTT GTT GGA AAA ATA AAA CGA GAA ATT 
Val Val Gly Lys Ile Lys Arg Glu Ile 
TAC CAA GTG ATC AGC ACT CCA ACA GAC 
Tyr Gln Val Ile Ser Thr Pro Thr Asp 
GAC TAC ATC TGT AAA CAC GGG AGG GTT 
Asp Tyr Ile Cys Lys His Gly Arg Val 
GCC GTG GAC TAC TGT CAC AGG CAC ATG 
Ala, Val Asp Tyr Cys His Arg His Met 
GCC CAG ATG AAT GCT AAG ATA GCT GAC 
Ala Gln Met Asn Ala Lys Ile A~a Asp 
ACT AGC TGT GGA TCG CCA AAT TAT GCA 
Thr Ser C~s Giy Ser Pro Asn Tyr Ala 
GTT GAT ATC TGG AGC TGT GGT GTT ATC 
Va] ASp Ile Trp Ser Cys Gly Val Ile 
CAC GTG CCT ACG CTC TTT AAG AAG ATC 
His Val Pro Thr Leu Phe Lys Lys Ile 
ATT GCC ACT CTG CTG ATG CAC ATG CTG 
Ile Ala Thr Leu Leu Met His Met Leu 
GAG CAT GAA TGG TTT AAA CAG GAT TTG 
Glu His Glu Trp Phe Lys Gln Asp Leu 
GTC ATT GAT GAT GAG GCT GTG AAA GAA 
Val Ile Asp Asp Glu Ala Val Lys Glu 
AGT TTA TAC AGT GGT GAC CCT CAA GAC 
Ser Leu Tyr Ser Gly Asp Pro Gln Asp 
ATA ATG AAC CAA GCC AGT GAG TTC TAC 
Ile Met Asn Gln Ala Ser Glu Phe Tyr 
GCC ATG CAC ATT CCC CCC GGC CTG AAA 
Ala Met His Ile Pro Pro Gly Leu Lys 
AAA GCA CGC TGT CCA CTG GAT GCA CTC 
Lys Ala Arg Cys Pro Leu Asp Ala Leu 
TGG CAC CTT GGG ATC CGA AGC CAG AGC 
Trp His Leu Giy Ile Arq Ser Gln Ser 
CAG CTG GAC TTT GAA TGG AAG GTA GTG 
Gln Leu Asp Phe Glu Trp Lys V~ V~I 
GGC AAT TAC GTG AAA AT(; AGC TTA CAG 
Gly Asn Tyr Val Lys ~t  S~r T~ Gin 
AGC ATC GAT GAT GAG GTG GTG GAG CAG 
Ser Ile Asp Asp Glu Val Val Glu Gln 
GGC CTC CAC AGA CCT CGG TCA AGT GTC 
Gly Leu His Arg Pro Arg Ser Ser Val 
ACT GGT TCT TTG ACT GGC AGC ACT TTG 
Thr Gly Ser Leu Thr Gly Ser Thr Leu 
TTT GAA ATG TGC GCC AGT CTT ATC ACT 
Phe GIu Met Cys Ala Ser Leu Ile Thr 
GTT ACC GCA CTG TGA AAT CAC ATA CAC 
AAT AGA AGT TAT GTG AAC ATT CCC AGG 
TTT ACT TTT AGA ACT CTG TAA CTC TGC 
TAT GTG CTT GAT GCC CTC TCC TTA AGT 
TTT GCA TGT GTT GAG TOC CGT GGG TGG 
AGG CGG COG AAC ATG GCT GAG AAG CAG 
l~Met Ala Glu Lys Gln 
GAC ACC CTG GGC GTC GGC ACC TTC GGC 
Asp Thr Leu G~ Val G/~I~ Thr Phe G~ 
GCA GTT AAG TTA AGA ' CAG 
Ala Val Lys Ile Leu ASh Arg Gln Lys 
CAA AAT CTT AAA CTC TTT CGT CAT CCT 
Gln Asn Leu Lys Leu Phe Arg His Pro 
TTT TTT ATG GTA ATG GAA TAT GTG TCT 
Phe Phe Met Val Met Glu Tyr Val Ser 
GAA GAG GTG GAA GCT CGC CGG CTC TTC 
Glu Glu Val Glu Ala Arq Arq Leu Phe 
GTT GTC CAC AGG GAC CTG AAG CCA GAG 
Val Val His Arg Asp Leu Lys Pro Glu 
TTC GGA CTC TCT AAT ATG ATG TCA GAT 
Phe Giy Leu Ser ASh Met Met Ser Asp 
GCA CCG GAG GTC ATC TCA GGA AGG CTG 
Ala Pro GI~ Val Ile Ser Giy Arq Leu 
CTG TAT GCC CTT CTC TGT GGC AOC CTC 
Leu Tyr Ala Leu Leu Cys Gly Thr Leu 
CGA GGG GGT GTG TTC TAC ATC CCG GAG 
Arg Gly Gly Val Phe Tyr Ile Pro Glu 
CAG GTG GAC CCC TTG AAG CGA GCA ACT 
Gln Val Asp Pro Leu Lys Arg Ala Thr 
CCC AGT TAC CTC TTT CCT GAA GAC CCC 
Pro Ser Tyr Le~ Phe Pro Glu Asp Pro 
GTA TGT GAA AAA TTT GAG TGT ACA GAA 
Val Cys Glu Lys Phe GIu Cys Thr GIu 
CAG CTC GCA GTG GCT TAT CAT CTC ATC 
Gln Leu Ala Val Ala Tyr His Leu Ile 
CTC GCC TCC AGT CCT CCA ACG GGT TCC 
Leu Ala Ser Ser Pro Pro Thr Gly Ser 
CCA CAT CCT GAA AGG ATG CCA CCT CTC 
Pro His Pro Glu Arg Met Pro Pro Leu 
AAC ACA ACT AAG CCC AAA TCT TTA GCT 
Asn Thr Thr Lys Pro Lys Ser Leu Ala 
AAA CCA TAC GAC ATT ATG GCG GAG GTG 
Lys Pro Tyr Asp Ile Met Ala Glu Val 
AAT GCA TAC CAT CTT CGA GTA AGA AGA 
A~n AIR Tvv M~.q T,~,11 Ar~ Val Arg Arg 
CTT TAC CTG GTT GAC GAT CGG AGC TAT 
Leu Tvr T~,e,_u VR] Ash Ash Ara Ser  Tvr  
AGG TCT GGT TCT TCA ACA CCT CAG CGC 
Arg Ser Gly Ser Ser Thr Pro Gln Arg 
GAT TCC AGC ACA GCC GAG AAC CAT TCA 
Asp Ser Ser Thr Ala Glu Asn His Ser 
TCC TOC GCT TOC CD~ CGC CTG GGC AGT 
Ser Ser Ala Ser Pro Arg Leu Gly Set 
GCT TTA GCC CGT TGA TAA CCC ACC ACC 
Ala Leu Ala Arg *** 
TCT TCA AAT TAT TAC CGC ACT CTC GGG 
TGA CAT GCA GTG CTG CTG GAA ACA CAG 
TGT GCC TAT GAT AGG TAT CAA TAG CTA 
2071 GGA ACG GCT GAG TGC TGG TGA AGC TTG TTA ACT TAC ACC CGT 
Fig. 2. Nucleotide and deduced amino acid sequence of full-length rat liver AMPKca t. Shown are the nucleotide and deduced amino acid sequences of a 
hybrid cDNA constructed from the 2.1 kb EcoRI fragment of a 3.2 kb cDNA isolated from library screening and from PCR-derived sequences. The 
sequence was confirmed by sequencing in two laboratories of this clone and other independent clones of 1.2 and 2.9 kb, both of which were contained 
within the 3.2 kb clone. The underlined amino acid sequences correspond to peptide sequences that are either identical or highly homologous to sequences 
obtained by direct peptide sequencing of the porcine liver enzyme (see Fig. 3). 
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was synthesized employing a degenerate primer designed 
from peptide sequence in the C-terminal end of the cat- 
alytic domain amino acid sequence [7] and mRNA from 
both rat and pig liver. AMPK63~ t cDNAs were then 
amplified using inosine-containing primers (and nested 
primers) corresponding to amino acid sequence in peptides 
recognized to align with the N- and C-terminal ends of the 
kinase catalytic domain. Using this protocol, 394 bp cD- 
NAs for both the rat and porcine enzymes were obtained. 
The deduced porcine and rat amino acid sequences were 
virtually identical (96%) with a 90% identity at the nu- 
cleotide level (Fig. 1A). 
3.2. Isolation of full-lengfli cDNA clones for AMPK63ca , 
The 394 bp catalytic domain PCR-derived cDNAs and 
degenerate oligonucleotides corresponding toother peptide 
sequences were used to screen a rat liver cDNA library. 
Several independent clones were isolated after plaque pu- 
rification. However, by sequence analysis, none of these 
clones contained a full-length uninterrupted reading frame 
for the kinase. The largest clone, 3.2 kb, did span a 
potential open reading frarne of 1.7 kb and additionally 1.1 
kb of the 3'-untranslated region, but had a 142 bp deletion 
(ascertained by comparison to the PCR-derived cDNAs) 
near its 5'-end (Fig. 1B). The 5'-end of other isolated 
clones began either within this sequence or just 5' to it,; 
these clones had variable extensions at the 3'-end (not 
shown). 
Sequence analysis of the 2.1 kb EcoRI fragment of the 
largest clone, as well as the overlaps in the other clones, 
reveals an putative start ATG at nucleotide 193 followed 
by an open reading frame predicted to code for a 552 
amino acid protein, with a termination codon at nucleotide 
1849 (Fig. 2). There is no in-frame termination codon 
upstream of this ATG, which prevents assignment of this 
methionine codon as the site of translation i itiation. How- 
ever, it does have features of the consensus equence of 
Kozak with a purine (A) at the - 3 position, C at positions 
- 1, - 4 and - 6 and a G at the + 4 position [15]. The 142 
bp sequence that is deleted in the 3.2 kb clone, but 
identified in the sequence of the 394 bp PCR product and 
in the other library clones, corresponds to nucleotides 
287-428 in the sequence shown in Fig. 2. 
Confirmation of the identity of the cloned cDNAs as 
corresponding to a rat homolog of the porcine AMPK63~a t
was obtained from inspection of the deduced amino acid 
sequence and from immunoprecipitation studies. Seven 
deduced rat peptide sequences either identical to or highly 
homologous to previously determined amino acid se- 
quences of isolated porcine AMPK63~a t were observed 
(Figs. 2 and 3). These peptide sequences lie both within 
and outside the catalytic domain core. Quantitative im- 
munoprecipitation f AMPK activity, either from isolated 
enzyme or from crude tissue/cell extracts, with antibodies 
directed against several peptide sequences has also been 
documented ( ata not shown). 
3.3. Comparison of rat AMPK63ca t sequence to other 
protein kinases 
The deduced amino acid sequence of AMPK63~ t in 
both the catalytic and non-catalytic domains was compared 
to that of other members of the protein kinase family. As 
PeDtide 
Rat (8--29) DGRVKIGHYVLGDTLGVGTFGK 
II111111:111111111111 
Pig DGRVKIGHYILGDTLGVGTFGK 
~ 2  
Rat (11.2-126) EEVEARRLFQQILSA 
I I illlillll 
Pig DEKESRRLFQQILSG 
PeDtide 
Rat(139-196) DLKPENVLLDAQMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVD 
lilllllIil Lll11111111iILllltlll ii l l l l l i l l l l l i l i l l l l 
Pig DLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXXAXXPNYAAPEVISGRLYAGPEVD 
PeDtide 
Rat (261-280) DIREHEWFKQDLPSYLFPED 
Ilillilillli iiIIli 
Pig DIREHEWFKQDLPKYLFPED 
PeDtide 
Rat (403-407) HLGIR 
llii 
Pig HLGIR 
PeDtide 
Rat (432-439) VVNAYHLR 
II I II 
Pig VVNPYYLR 
PeDtide 
Rat (453-468) MSLQLYLVDDRSYLLDFK 
IIIII II l:llllI: 
Pig MSLQLYQVDSRTYLLDFR 
Fig. 3. Confirmation of clone identity by comparison to pepfide sequence. Shown am the deduced sequences of ~ven peptides in the rM AMPKca t done 
shown m Fig. 2 compa~d ~ the seven p~viously determined pepfi~ sequences of the isolated powine liver 63 kDa protein [7]. The peptides are 
numbered 1 to 7 corresponding to ~eir oMer from the N-terminus, as underlined in F~. 2. 
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previously ascertained from directly determined amino acid 
sequence, AMPK63ca t is very homologous to the SNF1 
kinase [7]. In the catalytic domain of AMPK63cat, there is 
a 61-64% identity at the amino acid level to the SNF1 
kinase of S. cerevisiae and homologous kinases of the 
SNF1 kinase family from Arabodopsis, barley (H. vul- 
gate) and rye (S. cereale) (Fig. 4) [16-19]. This catalytic 
domain is likewise highly homologous to a kinase in fisson 
yeast (kin 1 +) and to two other S. cerevisiae kinases 
(KIN1 and KIN 2) (not shown) [20]. There is also strong 
catalytic domain homology to two other mammalian ki- 
nases, a murine embryo kinase (Emk) and a p78 human 
protein kinase eDNA ([21] and GenBank accession o. 
M80359) and to a C. elegans kinase (CELPAR2.3; Gen- 
Bank accession o. U00025). As with all members of the 
SNF1 family noted to date, the AMPK63ca t kinase cat- 
alytic domain (subdomains I-XI) occupies the N-terminal 
end of the molecule (Fig. 1B), in contrast o most other 
protein kinases, where the catalytic domain is in the C- 
terminus of the protein [11]. 
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Fig. 4. Comparison of the catalytic domain of rat liver AMPKca z to other members of the S~,~] ~nasc family. Shown is the amino acid alignment of the 
deduced sequence of the catalytic domain of AMPK~t (residues 15-281) to protein ~nases of ArabMopsis (ATI-IAI.YdN10A; residues 18-284), H. 
vulgare (barley) (HVBKIN1; residues 16-285), S. cereale (rye) (RKI1; residues 13-282) and the SNFZ kinase from S. cerevisiae (SNFI; residues 
54-319) [16-19]. Conserved residues identical to the AMPK sequence are shaded. The positions of the serine/threonine protein kinase catalytic subunit 
domains, as defined by Hanks et al. [11], are indicated with the Roman numerals; the invariant residues within each of these domains are indicated by 
underlining. The sequences were formatted by an Excel macro [14]. 
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The SNF1 family homologies of AMPK63ca t are not 
restricted to the catalytic domain. In the C-terminal half of 
the protein, there are three additional domains of 17-40 
amino acids, which are highly homologous to similar 
sequences in SNF1, Arabodopsis, barley and rye kinases 
(Figs. 1B and 5). Unlike the SNF1 subfamily, which 
includes kin1 +, KIN1, KIN2, p78 and Emk, there is not an 
ELKL (Glu-Leu-Lys-Leu) motif at the C-terminal tail [21]. 
We have also noted that the non-catalytic domain of 
AMPK63ca t contains a sequence (residues 368-392) ho- 
mologous to a domain in the Esk kinase (residues 368- 
392), a dual specificity kinase isolated from an embryonal 
carcinoma, which is not a member of the SNF1 kinase 
family [22] (alignment not shown). This finding led us to 
re-inspect the catalytic domain sequences, comparing it to 
other dual specificity kinases. It has been suggested that 
catalytic subdomains VIII and XI may be related to the 
novel specificity of several members of the STY kinase 
family, like Esk, in their ability to phosphorylate s rine, 
threonine and tyrosine residues [22,23]. While there is 
some homology of AMPK63ca t to several members of the 
STY kinase family in subdomain XI [22], subdomain VIII 
does not resemble that of the STY kinases [23] (compari- 
son not shown). The specific activity of the purified AMPK 
with the serine-containing SAMS peptide substrate is high 
at 11 ~mol/min per mg protein [7] and is unlikely to be 
higher for a tyrosine-containing substrate. Furthermore, we 
were unable to phosphorylate yrosine-containing peptides 
corresponding to the autophosphorylation sites in erbB or 
pp60src, to phenylalanine hydroxylase (residues 263-286) 
or to a sequence in feline immunodeficiency virus env 
(residues 680-711) (data not shown). For these reasons, 
we conclude that it is urdikely that AMPK63ca t exhibits 
any appreciable dual specificity. 
3.4. AMPK63c= t mRNA and activity distribution in rat 
tissues 
The level of expression of AMPK63ca t mRNA in rat 
tissues was assessed by Northern blotting, using [32 P]cDNA 
probes corresponding to the AMPK63ca t catalytic domain 
and to the 3'-UTR (Fig. 6). An identical pattern of expres- 
sion was observed with each probe. An 8.5 kb mRNA was 
observed; though expressed in all tissues except spleen, the 
highest concentration f message appears to be in skeletal 
muscle and heart. This contrasts with the measured activity 
of AMPK in tissue extracts, where liver expresses the 
highest level of activity and only low levels are detectable 
in heart or skeletal muscle (Table 1). This pattern of tissue 
activity distribution was also observed by Davies and 
coworkers, employing the same assay conditions [5]. 
3.5. Identification of  an mRNA species with a catalytic 
domain deletion 
The isolation from the library of cDNA clones with a 
142 bp deletion within the catalytic domain led us to 
examine several tissues for the presence of multiple 
AMPK63ca t mRNA species. On comparing the products 
derived from pig and rat liver cDNA by RT-PCR, it was 
noted that in the rat, but not the pig, two products of 394 
bp and 252 bp were produced (Fig. 7A). The latter product 
was subcloned and was found on DNA sequence analysis 
to lack the same 142 bp sequence identified as being 
'deleted' in the 3.2 kb clone (not shown). The same PCR 
primer sets were then used to examine the nature of the 
products obtained by RT-PCR from mRNA isolated from 
several rat tissues. On Southern analysis of these products 
(probing with the original PCR-derived 394 bp catalytic 
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Fig. 5. Comparison fthe non-catalytic C-terminal domain of rat liver AMPKca t to other members ofthe SNF1 kinase family. Shown are amino acid 
alignments ofthree subdomains within the non-catalytic C-terminal end of AMPKca t with non-catalytic subdomains of the members ofthe SNF1 ldnase 
family shown in Fig. 4. The numbers inparentheses r fer to the residue number ineach protein; the shaded amino acids are identical to the AMPK63ca t 
sequence. 
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28 S - 
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28 S - Eth id ium 
18 S - Bromide 
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Fig. 6. Northern analysis of AMPK63ca t mRNA distribution i  rat tissues. 
Shown is a representative Northern analysis of total RNA (20 /.Lg per 
lane) from several rat tissues and poly A+-RNA from lactating mammary 
gland (2 ~g). The numbers above and below the figure indicate the 
RNAs examined: 1 = spleen, 2 = lung, 3 = skeletal muscle, 4 = liver, 
5= heart, 6 = white adipose tissue, 7 = brain, 8 = kidney and 9 = 
lactating mammary gland. The separated RNAs were probed either with 
the PCR-derived 394 bp catalytic domain eDNA (upper panel) or with a 
1.1 kb eDNA corresponding to the 3'-untranslated region of AMPK63¢a t 
(middle panel), derived by EcoRI digestion of the 3.2 kb full-length 
clone. The bottom panel shows an ethidium bromide stain to indicate the 
equivalency of loading with respect to 28S ribosomal RNA content in the 
total RNA preparations employed. 
domain sequence), the same two PCR products derived 
from rat liver cDNA can be amplified from mRNA of 
nearly all rat tissues examined (except brain) (Fig. 7B). 
Table 1 
Distribution of AMPK Activity in rat tissues 
Tissue Activity 
(pmol /min/ /zg  protein) 
Liver 0.71 
Heart 0.16 
Skeletal muscle 0.04 
Kidney 0.15 
Lung 0.09 
Brain 0.07 
White adipose tissue 0.07 
Spleen 0.15 
Rat tissues were extracted for determination f AMPK activity in parallel 
with extraction of tissues for RNA isolation and the determination of
mRNA distribution shown in Fig. 6. AMPK activity, determined as in 
Section 2, is expressed as pmol/min per /.Lg extract protein. The data 
represent the average of two extracts of each tissue, which agreed within 
5%. 
.394 bp 
-252 bp 
Pig Rat 
394 bp- 
252 bp- 
Fig. 7. Identification of an AMPK63=t mRNA containing a catalytic 
domain deletion. (A) The ethidium bromide-stained PCR products de- 
rived by RT-PCR of pig and rat liver mRNA using the primer sets 
indicated in Section 2. (B) A Southern blot of RT-PCR products derived 
from various rat tissue mRNAs and the same primer sets. Following 
electrophoretic separation on a 1% agarose gel, the PCR-derived cDNAs 
were transferred to nitrocellulose, which was subsequently probed with 
the 32 P-labeled PCR-derived rat 394 bp catalytic domain cDNA. 
While this analysis is only semi-quantitative, it is evident 
that the 394 bp product, corresponding to 'undeleted' 
mRNA, is the major species obtained, although lung, liver 
and kidney display substantial amounts of the 252 bp 
product, corresponding to 'deleted' mRNA. 
4. Discussion 
Cloning of a cDNA for the catalytic subunit of the rat 
liver homolog of the porcine 5'-AMP-activated protein 
kinase (AMPK63ca t) confirms and extends information that 
was previously available from direct protein sequence 
analysis of the porcine enzyme [7]. As this work was being 
completed, another laboratory also reported the molecular 
cloning of a rat liver cDNA for this protein [1]. Our data 
are in general agreement with that report, but extend that 
information to the porcine enzyme and to a more thorough 
analysis of the mRNA species present and to the relation- 
ships to other deduced protein sequences. In addition, our 
sequence differs in the assignment of two amino acid 
residues, Ser355 (instead of Met) and Asp461 (instead of 
Asn). 
The most striking feature of the deduced/determined 
amino sequences of AMPK63=t from both species is the 
very strong homology to several members of the SNF1 
kinase family [16-21]. This homology is strongest in the 
N-terminal catalytic domain, but three homologous do- 
mains have also been identified in the C-terminal non-cata- 
lytic end of the protein. The function of these latter 
domains remains to be determined; it is possible they are 
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important in kinase regulation, interaction with other ki- 
nase subunits or in substrate recognition. 
In addition to the stril~ing evolutionary conservation of 
structure of these members of the SNF1 kinase family, 
there is also a striking parallelism in the functional roles of 
some members of this family. As defined in a series of 
studies by Carlson and co-workers, the SNF1 kinase in S. 
cerevisiae serves directly or indirectly as a glucose sensor 
[17,24,25]. When glucose is limiting, SNF1 kinase activity 
is necessary for the derepression of the Suc2 gene, thus 
allowing the metabolism of sucrose or raffinose [17,24-26]. 
Likewise, AMPK also serves as a metabolic sensor. When 
ATP levels are decreased (and 5'-AMP levels increased) in 
mammalian cells by glucose depletion, uncoupling of oxi- 
dation phosphorylation r by ATP 'trapping' (by incuba- 
tion of cells with fructose or 2-deoxyglucose), AMPK is 
activated [27-31]. Thus, both SNF1 and AMPK activities 
are modulated by substrate availability, although the exact 
mechanisms by which such regulation occurs for SNF1 
remains to be fully elucidated. SNF1 is not activated by 
5'-AMP [7]. In mammalian systems, 5'-AMP, in addition to 
its allosteric activation of AMPK, has been reported to 
increase its phosphorylation byan activating kinase/kinase 
[4,8]. 
Although isolated as a kinase thought to be active 
principally on lipid synthesizing enzymes (acetyl-CoA car- 
boxylase, HMG-CoA reductase), it seems quite likely that 
AMPK will prove to haw~ a broader ange of intracellular 
substrates. The striking levels of AMPK63ca t mRNA in 
non-lipogenic tissues, like heart and skeletal muscle, are 
certainly consistent with this view. AMPK could serve a 
more general role to diminish the activity of ATP-utilizing 
pathways when substrate fuel (e.g. glucose, 02) and/or 
ATP is lacking or diminished. This could occur either by 
the rapid post-translational regulation of several key 
metabolic enzymes or by regulating their level of gene 
expression. Conversely, heightened AMPK activity would 
also serve to increase ATP generation indirectly through 
its rapid modulation of acetyl-CoA carboxylase activity 
[32]. In this model, a diminution in available glucose, 
leading to AMPK activation, would cause the phosphoryla- 
tion and inactivation of ACC, causing intracellular mal- 
onyl-CoA levels to fall. The fall in malonyl CoA would 
relieve the allosteric inhibition of mitochondrial carnitine 
palmitoyltransferase I, permitting increased entry of fatty 
acids into mitochondria for oxidation, thus repleting ATP 
[33]. In this way, ACC and AMPK could act together as 
metabolic sensor/effector allowing smooth transitions be- 
tween the use of glucose and fatty acid as oxidative fuel. 
The pivotal role of ACC in this transition in cardiac 
muscle has previously been recognized [33]. 
The level of expression of AMPK63~a t mRNA is dis- 
cordant with the level of expression of AMPK activity in 
rat tissues. Surprisingly, heart and skeletal muscle ex- 
pressed very high level.,; of mRNA, but low levels of 
activity; liver, in contrast, expressed the highest activity, 
but relatively low levels of mRNA. There are several 
explanations for this discordance ranging from differences 
in mRNA translation to post-translation modification. 
AMPK is itself subject of phosphorylation by a 
kinase/kinase, which results in increased AMPK activity 
[8]. It is possible that the heart and skeletal muscle en- 
zymes are largely in an inactive state under the conditions 
of the present experiments. The role of the other AMPK 
subunits in regulating enzyme activity could also be piv- 
otal to understanding this discordance. Although it is 
claimed that the SAMS peptide is specific for AMPK [5], 
it can also be phosphorylated by the SNF1 kinase and 
other kinases which are not 5'-AMP-activated [6,7]. It is 
possible that mammalian tissues contain multiple kinases 
active on the SAMS peptide, which might also contribute 
to divergence between the level of a specific mRNA and 
peptide kinase activity. 
Remarkably, several rat tissues contain a species of 
AMPK63ca t mRNA which has an 'out-of-frame' deletion 
of 142 bp within the catalytic domain, encompassing ki- 
nase catalytic subdomains II, III and IV [11]. In addition to 
the deletions of these subdomains, this deletion also cre- 
ates a stop codon and thus this mRNA would not encode 
for a functional kinase species. It is possible that a trun- 
cated polypeptide product derived from the translation of 
this mRNA could serve to inhibit functional kinase 
polypeptide by a dominant/negative interaction. Alterna- 
tively, the excision of this sequence from mRNA precursor 
could serve as a level of cellular control to regulate the 
amount of translatable mRNA. The unexpected presence of 
this 'deleted' mRNA, while varying between tissues, does 
not account for the discepancy between Northern analysis 
and kinase activity in the tissues examined, since an 
identical distribution of mRNA was seen either with a 
catalytic domain or 3'-UTR probe. 
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